ACC Cardiology Hour | ACC.24
In the latest installment of ACC Cardiology Hour, supported by Esperion, Valentin Fuster, MD, PhD, MACC, as well as expert panelists Clyde Yancy, MD, MSc, MACC; Rasha Al-Lamee, MD, PhD; Julia Indik, MD, PhD, FACC; and Vinod Thourani, MD, FACC, discuss the top late-breaking clinical trials released during ACC.24. Don't miss key takeaways and expert analysis on the practice implications of RELIEVE-HF (02:23), EMPACT-MI (12:48), The DanGer-Shock Trial (20:19), AEGIS-II CSL112 (28:12), Phase 2 Kardia 2 (37:10), PREVENTIVE-PCI (46:19), ORBITA-COSMIC (53:37), and IMPROVE-HCM (1:01:02). Additionally, watch the "Best of ACC.24" pick from each panelist (1:06:06).
A long-standing resource for busy cardiovascular professionals, ACC Cardiology Hour offers multidisciplinary expert discussion on top clinical trials released during cardiology's biggest meetings. Visit https://www.JACC.org/CardiologyHour to see more videos.
ACC.org will provide coverage of all the late-breaking science being presented at ACC.24 to help you find out how it all fits into your practice. For trial summaries, news coverage, daily video wrap-ups and more, visit ACC's Meeting Coverage Page. Follow the ACC on Social Media and use the hashtag #ACC24 to join the conversation.
Clinical Topics: Acute Coronary Syndromes, Heart Failure and Cardiomyopathies, Invasive Cardiovascular Angiography and Intervention, Prevention, Atherosclerotic Disease (CAD/PAD), Acute Heart Failure, Interventions and ACS, Interventions and Coronary Artery Disease, Hypertension
Keywords: ACC Annual Scientific Session, ACC24, Heart Failure, Implantable Devices, Myocardial Infarction, Heart Failure, Novel Agents, Sodium-Glucose Transporter 2 Inhibitors, Percutaneous Coronary Intervention, Acute Coronary Syndrome, Implantable Devices, Myocardial Infarction, Acute Coronary Syndrome, Stroke, Hypertension, RNA Interference, Coronary Artery Disease, Atherosclerosis, Cardiomyopathies
< Back to Listings
